文献速递甲状腺疾病

原发性甲状腺淋巴瘤与各类甲状腺自身免疫的关系:498例回顾性队列研究,含9例Graves病

The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease.
PubMed 文献 · Thyroid · 2022-04-12

该单中心回顾性队列研究分析了1979年8月至2021年10月间498例原发性甲状腺淋巴瘤(PTL)患者,按有无Graves病(GD)、桥本甲状腺炎(HT)或无自身免疫性甲状腺疾病(AITDs)分组。多数PTL患者合并HT(86.6%),仅1.8%合并GD。GD组与HT组或无AITDs组在PTL病理亚型比例及总生存、无事件生存上均无显著差异。

要点

  • 498例PTL中,431例(86.6%)合并HT,9例(1.8%)合并GD,58例(11.6%)无AITDs。
  • 9例GD患者抗甲状腺球蛋白抗体和/或抗甲状腺过氧化物酶抗体均为阳性,且均接受抗甲状腺药物治疗。
  • GD组与HT组或无AITDs组在PTL各病理亚型比例及生存上均无显著差异。

核心结论

  • PTL多数合并HT,少数合并GD(1.8%);GD组与HT组或无AITDs组在PTL病理亚型比例及预后上无差异。

研究设计与样本

  • 单中心回顾性队列研究,回顾1979年8月至2021年10月诊断的498例PTL患者病历,按有无HT、GD或无AITDs分组。
  • 病理标本按世界卫生组织分类,分期采用Ann Arbor分类。

主要发现

  • 498例PTL患者中位年龄68岁(四分位距61-76),221例为IE期,余277例为IIE期。
  • 431例(86.6%)合并HT,9例(1.8%)合并GD,58例(11.6%)无AITDs。
  • 9例GD患者抗甲状腺球蛋白抗体和/或抗甲状腺过氧化物酶抗体均为阳性,且均接受抗甲状腺药物治疗。
  • GD组与全部PTL患者、HT组或无AITDs组在PTL各病理亚型比例上均无显著差异(p值分别为0.51、0.51、0.48)。
  • 中位随访6.2年(四分位距3.0-10.7),Kaplan-Meier分析显示GD组与HT组总生存和无事件生存无显著差异(p=0.37),GD组与无AITDs组亦无显著差异(p=0.43)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Primary thyroid lymphoma (PTL) is known to develop mostly in patients with Hashimoto's thyroiditis (HT), and it is rare for it to develop in patients with Graves' disease (GD). The objective of this study was to investigate the clinical features, pathological findings, and long-term outcomes of PTL patients, grouped according to the presence of GD, HT, or no autoimmune thyroid disease (AITDs). The GD group was of major interest due to limited knowledge of the relationship with PTL. Methods: In this single-center retrospective cohort study, we reviewed the medical records of all patients diagnosed with PTL between August 1979 and October 2021, and we characterized the patients according to the presence of HT, GD, or no AITDs. Pathological specimens were classified according to the World Health Organization classification. Staging was performed in accordance with the Ann Arbor classification. Results: During the 42-year period, 498 participants were diagnosed with PTL. The median age was 68 (interquartile range 61-76) years, and 221 patients were stage IE, whereas the remaining 277 patients were stage IIE. Of the PTL patients, 431 (86.6%) were diagnosed with HT, 9 (1.8%) were diagnosed with GD, and 58 (11.6%) did not have AITDs. All nine patients with GD were positive for anti-thyroglobulin antibody and/or anti-thyroid peroxidase antibody. All patients with GD were treated with anti-thyroid medication. There were no significant differences in the proportions of each subtype of PTL between the PTL patients with GD and all subjects with PTL (p = 0.51), PTL patients with HT (p = 0.51), or PTL patients without AITDs (p = 0.48). The median follow-up time was 6.2 (interquartile range 3.0-10.7) years after the diagnosis of PTL. The Kaplan-Meier curve analyses showed no significant differences in overall survival and event-free survival between PTL patients with GD and those with HT (p = 0.37), or between PTL patients with GD and those without AITDs (p = 0.43). Conclusions: The PTL was observed with HT in a majority of cases, and rarely with GD (1.8%). The proportions of each pathological subtype of PTL and the prognosis of PTL were not different between the patients with GD and those with HT or those without AITDs.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Suzuki N, Watanabe N, Noh JY, et al. The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease. Thyroid. 2022. PMID: 35229626. doi:10.1089/thy.2021.0613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。